PDCL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.055800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.480200E-01
Normal-vs-Stage2
2.699000E-01
Normal-vs-Stage3
5.892100E-02
Normal-vs-Stage4
9.477800E-01
Stage1-vs-Stage2
7.250800E-01
Stage1-vs-Stage3
2.924600E-01
Stage1-vs-Stage4
5.316400E-01
Stage2-vs-Stage3
2.131200E-01
Stage2-vs-Stage4
1.699800E-01
Stage3-vs-Stage4
1.468410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.617800E-01
Normal-vs-AfricanAmerican
5.461800E-01
Normal-vs-Asian
5.486400E-01
Caucasian-vs-AfricanAmerican
6.342000E-01
Caucasian-vs-Asian
5.158400E-01
AfricanAmerican-vs-Asian
9.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.665400E-01
Normal-vs-Female
3.733200E-01
Male-vs-Female
3.744400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.007600E-01
Normal-vs-Age(41-60Yrs)
5.019400E-01
Normal-vs-Age(61-80Yrs)
2.574600E-01
Normal-vs-Age(81-100Yrs)
2.081600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.734400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.413800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.503600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.969600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.573030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.342800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.271000E-01
Normal-vs-Daily Drinker
8.200000E-02
Normal-vs-Weekly Drinker
2.892200E-01
Normal-vs-Occasional Drinker
5.317200E-01
Normal-vs-Social Drinker
6.010200E-01
Non Drinker-vs-Daily Drinker
9.550000E-01
Non Drinker-vs-Weekly Drinker
3.264600E-01
Non Drinker-vs-Occasional Drinker
1.288220E-01
Non Drinker-vs-Social Drinker
7.786400E-02
Daily Drinker-vs-Weekly Drinker
2.826200E-01
Daily Drinker-vs-Occasional Drinker
1.198640E-01
Daily Drinker-vs-Social Drinker
6.632100E-02
Weekly Drinker-vs-Occasional Drinker
6.410200E-01
Weekly Drinker-vs-Social Drinker
4.674800E-01
Occasional Drinker-vs-Social Drinker
8.076400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.381980E-01
Normal-vs-Grade 2
3.551800E-02
Normal-vs-Grade 3
6.023600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.502000E-01
Grade 1-vs-Grade 3
7.287600E-01
Grade 1-vs-Grade 4
1.381980E-01
Grade 2-vs-Grade 3
5.104800E-01
Grade 2-vs-Grade 4
3.551800E-02
Grade 3-vs-Grade 4
6.023600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.878400E-01
Normal-vs-NonDiabetic
2.476400E-01
Diabetic-vs-NonDiabetic
8.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.509840E-02
Normal-vs-NoPancreatitis
3.149600E-01
Pancreatitis-vs-NoPancreatitis
3.073700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.927200E-01
Normal-vs-N1
2.821600E-01
N0-vs-N1
7.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.162800E-01
Normal-vs-TP53-NonMutant
4.133800E-01
TP53-Mutant-vs-TP53-NonMutant
5.098200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
